Acetyl starch
Alternative Names: Acetylamylopectin; ACSLatest Information Update: 24 Oct 2021
At a glance
- Originator Braun Melsungen; Johann Wolfgang Goethe Universitatsklinikum
- Class Plasma expanders
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypovolaemia
Most Recent Events
- 26 Apr 2004 Discontinued - Phase-II for Hypovolaemia in Germany (IV-infusion)
- 30 Aug 2000 Phase-II clinical trials for Hypovolaemia in Germany (IV-infusion)